Recent industry deals includes Abbott’s $2.8 billion acquisition of Santa Ana-based AMO, and Medtronic’s more than $700 million buyout of Irvine-based CoreValve. The presentation will focus on the planning, structuring and execution of the transactions.

“This will be a unique business conference for the exchange of ideas among public and private medical device companies, doctors, start-ups, scientists and leading venture capital firms,” says Aliso Viejo-based OCTANe President and CEO Matthew Jenusaitis.

He says the event will “showcase California innovation at its finest.” And it’s true: Professionals from around the county, nation and the world – from as far as France and Australia – are attending, hoping to learn about the region’s promising medical sector.

A range of additional topics will be discussed, such as opthalmology, device design and global opportunities.

Among the speakers during the forum: Christopher Cox, former SEC chairman, who will highlight health care policy and reform during his Nov. 10 lunch keynote. Others include Dan Lemaitre, former CoreValve CEO; James Mazzo, president of Abbott Medical Optics and senior vice president of Abbott; and Scott Gottlieb, M.D., a resident fellow at the American Enterprise Institute and former deputy commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration.

OCTANe works to accelerate entrepreneurs and company development for Orange County’s biomedical and technology communities.